scholarly journals Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis

2006 ◽  
Vol 78 (4) ◽  
pp. 367-371 ◽  
Author(s):  
J H Veldink ◽  
S Kalmijn ◽  
G-J Groeneveld ◽  
W Wunderink ◽  
A Koster ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Amyotrophic Lateral Sclerosis ◽  
Vitamin E ◽  
Polyunsaturated Fatty Acids ◽  
Lateral Sclerosis

scholarly journals Prediagnostic plasma polyunsaturated fatty acids and the risk of amyotrophic lateral sclerosis

Neurology ◽  
2019 ◽  
Vol 94 (8) ◽  
pp. e811-e819 ◽  
Author(s):  
Éilis J. O'Reilly ◽  
Kjetil Bjornevik ◽  
Jeremy D. Furtado ◽  
Laurence N. Kolonel ◽  
Loic Le Marchand ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Amyotrophic Lateral Sclerosis ◽  
Arachidonic Acid ◽  
Polyunsaturated Fatty Acids ◽  
Conditional Logistic Regression ◽  
Gas Liquid Chromatography ◽  
Blood Draw ◽  
Total N ◽  
Bottom Quartile ◽  
Lateral Sclerosis

ObjectiveTo examine the association between prediagnostic plasma polyunsaturated fatty acids levels (PUFA) and amyotrophic lateral sclerosis (ALS).MethodsWe identified 275 individuals who developed ALS while enrolled in 5 US prospective cohorts, and randomly selected 2 controls, alive at the time of the case diagnosis, matched on cohort, birth year, sex, ethnicity, fasting status, and time of blood draw. We measured PUFA, expressed as percentages of total fatty acids, using gas liquid chromatography and used conditional logistic regression to estimate risk ratios (RR) and 95% confidence intervals (CI) for the association between PUFA and ALS.ResultsThere was no association between total, n-3, and n-6 PUFA, eicosapentaenoic acid, or docosapentaenoic acid levels and ALS. Higher plasma α-linolenic acid (ALA) in men was associated with lower risk of ALS in age- and matching factor-adjusted analyses (top vs bottom quartile: RR = 0.21 [95% CI 0.07, 0.58], p for trend = 0.004). In women, higher plasma arachidonic acid was associated with higher risk (top vs bottom quartile: RR = 1.65 [95% CI 0.99, 2.76], p for trend = 0.052). Multivariable adjustment, including correlated PUFA, did not change the findings for ALA and arachidonic acid. In men and women combined, higher plasma docosahexaenoic acid (DHA) was associated with higher risk of ALS (top vs bottom quartile: RR = 1.56 [95% CI 1.01, 2.41], p for trend = 0.054), but in multivariable models the association was only evident in men.ConclusionsThe majority of individual PUFAs were not associated with ALS. In men, ALA was inversely and DHA was positively related to risk of ALS, while in women arachidonic acid was positively related. These findings warrant confirmation in future studies.

Vitamin E Content and Estimated Need in German Infant and Follow-On Formulas With and Without Long-Chain Polyunsaturated Fatty Acids (LC-PUFA) Enrichment

2014 ◽  
Vol 62 (41) ◽  
pp. 10153-10161 ◽  
Author(s):  
Madlen Stimming ◽  
Christina M. Mesch ◽  
Mathilde Kersting ◽  
Hermann Kalhoff ◽  
Hans Demmelmair ◽  
...  
Keyword(s):  
Fatty Acids ◽  
Vitamin E ◽  
Polyunsaturated Fatty Acids ◽  
Long Chain

scholarly journals Nutrition and lysosomal activity. The effect of dietary cod-liver oil on the distribution of polyunsaturated fatty acids in the kidney lysosomes of rats receiving deficient or adequate intakes of vitamin E

1969 ◽  
Vol 23 (1) ◽  
pp. 31-39 ◽  
Author(s):  
M. Iqbal ◽  
J. T. Dingle ◽  
T. Moore ◽  
I. M. Sharman
Keyword(s):  
Fatty Acids ◽  
Vitamin E ◽  
Polyunsaturated Fatty Acids ◽  
Partial Replacement ◽  
Reverse Direction ◽  
Cod Liver Oil ◽  
Post Mortem ◽  
Dietary Changes ◽  
General Metabolism ◽  
Arachidonic Acids

1. In an attempt to explain the antagonism between polyunsaturated fatty acids (PUFA) and vitamin E in the promotion of post-mortem autolysis and increased lysosomal fragility in the kidney of rats, studies were made by gas chromatography of the incorporation of PUFA into the lysosomes.2. Kidneys were taken from rats that had received various diets, which differed in their fat components and which were with or without vitamin E. Since the inclusion of cod-liver oil in the diet reduces the period of dietary preparation necessary for rapid kidney autolysis, the effect of this oil on the PUFA distribution in the lysosomes was specially studied.3. In purified preparations of kidney lysosomes from rats that had received substantial amounts of cod-liver oil for several weeks, C 20:5 acid was incorporated mainly at the expense of C 18:2 (linoleic) and C 20:4 (arachidonic) acids. In less purified lysosomal fractions the incorporation of C 20:5 and C 22:6 acids and the corresponding reductions in linoleic and arachidonic were well advanced after 10 days, but were not maximal until about 30 days. The same changes took place in the reverse direction, with about the same rapidity, when rats that had previously been given cod-liver oil were changed to a diet containing lard.4. The percentage of PUFA in the kidney lysosomes of rats not dosed with vitamin E was not significantly different from that of rats given adequate doses.5. Thus the increased tendency to kidney autolysis, and the reduced stability of the lysosomes, caused by the feeding of cod-liver oil were associated with the partial replacement of linoleic acid and of the endogenous arachidonic acid by an acid, usually foreign to the rat, which is even more unsaturated. Since vitamin E did not prevent the entry of this acid into the lysosomes its potency in retarding autolysis and stabilizing the lysosomes must be exerted at some point subsequent to the incorporation of PUFA.6. Since change in the percentage of lysosomal PUFA in response to dietary changes is slow, this suggests that the lysosornal lipidsescape usage in general metabolism as an immediate source of calories and that they have a half-life of at least 15 days. Individual fatty acids, however, may differ in their half-lives.

scholarly journals Efficacy of Polyunsaturated Fatty Acids on Inflammatory Markers in Patients Undergoing Dialysis: A Systematic Review with Network Meta-Analysis of Randomized Clinical Trials

2019 ◽  
Vol 20 (15) ◽  
pp. 3645 ◽  
Author(s):  
Po-Kuan Wu ◽  
Shu-Ching Yeh ◽  
Shan-Jen Li ◽  
Yi-No Kang
Keyword(s):  
Fatty Acids ◽  
Clinical Trials ◽  
Vitamin E ◽  
Polyunsaturated Fatty Acids ◽  
Inflammatory Markers ◽  
Randomized Clinical Trials ◽  
Meta Analysis ◽  
C Reactive Protein ◽  
Reactive Protein ◽  
Hs Crp

The effects of polyunsaturated fatty acids (PUFAs) on inflammatory markers among patients receiving dialysis have been discussed for a long time, but previous syntheses made controversial conclusion because of highly conceptual heterogeneity in their synthesis. Thus, to further understanding of this topic, we comprehensively gathered relevant randomized clinical trials (RCTs) before April 2019, and two authors independently extracted data of C-reactive protein (CRP), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) for conducting network meta-analysis. Eighteen eligible RCTs with 962 patients undergoing dialysis were included in our study. The result showed that with placebo as the reference, PUFAs was the only treatment showing significantly lower CRP (weighted mean difference (WMD): −0.37, 95% confidence interval (CI): −0.07 to −0.68), but the CRP in PUFAs group was not significantly lower than vitamin E, PUFAs plus vitamin E, or medium-chain triglyceride. Although no significant changes were noted for hs-CRP and IL-6 levels, PUFAs showed the best ranking among treatments according to surface under the cumulative ranking. Therefore, PUFAs could be a protective option for patients receiving dialysis in clinical practice.

Sign in / Sign up

Export Citation Format

Share Document